Cyproheptadine blockade of a cardiogenic hypertensive chemoreflex.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D002628:Chemoreceptor Cells / Q000187:drug effects; D003533:Cyproheptadine / Q000494:pharmacology*; D004285:Dogs; D004558:Electric Stimulation; D005260:Female; D006321:Heart / Q000294:innervation / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects*; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D009200:Myocardial Contraction / Q000187:drug effects*; D012018:Reflex / Q000187:drug effects*; D012701:Serotonin / Q000494:pharmacology*; D012702:Serotonin Antagonists; D012849:Sinoatrial Node / Q000187:drug effects; D013233:Stellate Ganglion / Q000187:drug effects
D012702:Serotonin Antagonists; D003533:Cyproheptadine; D012701:Serotonin; D009020:Morphine; D001285:Atropine; D008784:Methysergide